GlassScriptPhysician profile
Alan Gegenheimer
NPI 1730119561
$1,362.93
in general payments reported to CMS, 2019-2025
16 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $485 · 2020: $104 · 2021: $106 · 2022: $119 · 2023: $127 · 2024: $316 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $547.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $532.45 | 2019-2025 | Euflexxa |
| Depuy Synthes Sales INC. | $211.06 | 2020-2025 | Monovisc, Orthovisc, Na |
| Wright Medical Technology, INC. | $110.61 | 2019 | |
| Zimmer Biomet Holdings, INC. | $96.57 | 2019-2022 | |
| Axogen | $96.34 | 2019 | |
| Highridge Medical LLC | $44.76 | 2024-2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System, Biomet Ebi Bone Healing System |
| Ethicon US, LLC | $42.06 | 2019 | |
| Catalyst Orthoscience | $34.21 | 2019 | |
| Ebi, LLC | $31.87 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Endo Pharmaceuticals INC. | $31.84 | 2019 | |
| Convatec INC. | $31.40 | 2024 | |
| Stryker Corporation | $30.71 | 2019 | |
| Pacira Therapeutics, INC. | $28.02 | 2020 | |
| Arteriocyte Medical Systems, INC. | $18.40 | 2019 | |
| Arthrosurface Incorporated | $13.03 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electronic Waveform Lab, INC. | $9.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Gegenheimer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.